Nation's Leading Sperm Bank Opens Branch in New York City

Friday, September 18, 2009 General News
Email Print This Page Comment
Font : A-A+



NEW YORK, Aug. 11 California Cryobank, the nation's leading sperm bank has acquired Park Avenue Fertility, located in the heart of Manhattan. The acquisition marks the first time that any national sperm bank will be able to offer local services in both Los Angeles and New York - the country's two largest markets for reproductive medicine.

"California Cryobank has always aimed at providing the highest standards of service possible," Dr. Charles Sims, co-founder, explains. "Our Park Avenue facility will allow residents of the tri-state area convenient and direct access to all of our services, including local donor specimen pickup within the next few months."

California Cryobank regularly ships all over the United States and provides local services in Los Angeles, CA, Palo Alto, CA, and Cambridge, MA. The new Park Avenue facility means their New York area clients can save hundreds of dollars in shipping fees.

This acquisition will also enable California Cryobank to expand the diversity of its donors in one of the world's premier cities. Sims believes this is a key factor for clients. "Finding as wide a variety of highly-qualified donors as possible is extremely important. We want our clients to be able to find their ideal donor and to do that, they need a wide variety of donors from which to choose."

In order to maintain the current number of nearly 300 donors, the recruiting process never stops. This is due to a combination of the stringent donor eligibility requirements and limits on the number of allowed donations. Less than 1% of all applicants actually become fully qualified California Cryobank donors.

"We're tough," Sims says with a smile, "but I'm confident the men of New York are up to the challenge."

For more information please contact media@cryobank.com or call 310-496-5681.

SOURCE California Cryobank


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook